Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 169

1.

Targeted proteomics reveals promising biomarkers of disease activity and organ involvement in antineutrophil cytoplasmic antibody-associated vasculitis.

Ishizaki J, Takemori A, Suemori K, Matsumoto T, Akita Y, Sada KE, Yuzawa Y, Amano K, Takasaki Y, Harigai M, Arimura Y, Makino H, Yasukawa M, Takemori N, Hasegawa H; Research Committee of Intractable Vasculitis Syndrome and the Research Committee of Intractable Renal Disease of the Ministry of Health, Labour and Welfare of Japan.

Arthritis Res Ther. 2017 Sep 29;19(1):218. doi: 10.1186/s13075-017-1429-3.

2.

Rituximab-Resistant Nephrotic Syndrome With Successful Induction of Remission by Low-Density Lipoprotein Apheresis.

Suzuki H, Tsukamoto T, Muso E.

Ther Apher Dial. 2017 Jun;21(3):295-296. doi: 10.1111/1744-9987.12561. No abstract available.

PMID:
28661090
3.

A clinical evaluation of renal amyloidosis in the Japan renal biopsy registry: a cross-sectional study.

Nishi S, Muso E, Shimizu A, Sugiyama H, Yokoyama H, Ando Y, Goto S, Fujii H.

Clin Exp Nephrol. 2017 Aug;21(4):624-632. doi: 10.1007/s10157-016-1326-0. Epub 2016 Aug 25.

PMID:
27562765
4.

Identification of MMP1 as a novel risk factor for intracranial aneurysms in ADPKD using iPSC models.

Ameku T, Taura D, Sone M, Numata T, Nakamura M, Shiota F, Toyoda T, Matsui S, Araoka T, Yasuno T, Mae S, Kobayashi H, Kondo N, Kitaoka F, Amano N, Arai S, Ichisaka T, Matsuura N, Inoue S, Yamamoto T, Takahashi K, Asaka I, Yamada Y, Ubara Y, Muso E, Fukatsu A, Watanabe A, Sato Y, Nakahata T, Mori Y, Koizumi A, Nakao K, Yamanaka S, Osafune K.

Sci Rep. 2016 Jul 15;6:30013. doi: 10.1038/srep30013.

5.

IFI27 Is a Useful Genetic Marker for Diagnosis of Immunoglobulin A Nephropathy and Membranous Nephropathy Using Peripheral Blood.

Nagasawa Y, Okuzaki D, Muso E, Yamamoto R, Shinzawa M, Iwasaki Y, Iwatani H, Nakanishi T, Isaka Y, Nojima H.

PLoS One. 2016 Apr 21;11(4):e0153252. doi: 10.1371/journal.pone.0153252. eCollection 2016.

6.

Evidence-based clinical practice guidelines for rapidly progressive glomerulonephritis 2014.

Arimura Y, Muso E, Fujimoto S, Hasegawa M, Kaname S, Usui J, Ihara T, Kobayashi M, Itabashi M, Kitagawa K, Hirahashi J, Kimura K, Matsuo S.

Clin Exp Nephrol. 2016 Jun;20(3):322-41. doi: 10.1007/s10157-015-1218-8. Review. No abstract available.

7.

[Vasculitis].

Muso E, Arimura Y.

Nihon Jinzo Gakkai Shi. 2016;58(1):5-11. Review. Japanese. No abstract available.

PMID:
26950975
8.

A Prospective Observational Survey on the Long-Term Effect of LDL Apheresis on Drug-Resistant Nephrotic Syndrome.

Muso E, Mune M, Hirano T, Hattori M, Kimura K, Watanabe T, Yokoyama H, Sato H, Uchida S, Wada T, Shoji T, Takemura T, Yuzawa Y, Ogahara S, Sugiyama S, Iino Y, Sakai S, Ogura Y, Yukawa S, Nishizawa Y, Yorioka N, Imai E, Matsuo S, Saito T.

Nephron Extra. 2015 Aug 29;5(2):58-66. doi: 10.1159/000437338. eCollection 2015 May-Aug.

9.

Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study.

Sada KE, Yamamura M, Harigai M, Fujii T, Takasaki Y, Amano K, Fujimoto S, Muso E, Murakawa Y, Arimura Y, Makino H; Research Committee on Intractable Vasculitides, the Ministry of Health, Labour and Welfare of Japan.

Arthritis Res Ther. 2015 Nov 2;17:305. doi: 10.1186/s13075-015-0815-y.

10.

[Multidisciplinary care improves the clinical outcome of CKD patients: approaches of Kitano Hospital to CKD team care].

Suzuki H, Nakamura M, Shigeta Y, Yonemoto S, Muso E.

Nihon Jinzo Gakkai Shi. 2015;57(5):833-44. Japanese. No abstract available.

PMID:
26387376
11.

[Preface: Education about kidney disease and team medicine].

Muso E.

Nihon Jinzo Gakkai Shi. 2015;57(5):804-5. Japanese. No abstract available.

PMID:
26387371
12.

Exploring the origin and limitations of kidney regeneration.

Endo T, Nakamura J, Sato Y, Asada M, Yamada R, Takase M, Takaori K, Oguchi A, Iguchi T, Higashi AY, Ohbayashi T, Nakamura T, Muso E, Kimura T, Yanagita M.

J Pathol. 2015 Jun;236(2):251-63. doi: 10.1002/path.4514. Epub 2015 Mar 4.

PMID:
25664690
13.

Gender- and disease-specific urinary thioredoxin in chronic kidney disease patients with or without type 2 diabetic nephropathy.

Tobino K, Muso E, Iwasaki Y, Yonemoto S, Kasuno K, Tsukamoto T, Nakamura H, Tomino Y.

Nephrology (Carlton). 2015 May;20(5):368-74. doi: 10.1111/nep.12403.

PMID:
25615414
14.

Pulmonary involvements of anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis in Japan.

Hirayama K, Kobayashi M, Usui J, Arimura Y, Sugiyama H, Nitta K, Muso E, Wada T, Matsuo S, Yamagata K; Japanese RPGN Study Group of Progressive Renal Disease.

Nephrol Dial Transplant. 2015 Apr;30 Suppl 1:i83-93. doi: 10.1093/ndt/gfu385. Epub 2015 Jan 22.

PMID:
25613541
15.

Long-term safety and efficacy of rituximab in 7 Japanese patients with ANCA-associated vasculitis.

Nagafuchi H, Atsumi T, Hatta K, Muso E, Takeno M, Yamada H, Ozaki S.

Mod Rheumatol. 2015 Jul;25(4):603-8. doi: 10.3109/14397595.2014.981945. Epub 2014 Dec 15.

PMID:
25496405
16.

Renal redox dysregulation in AKI: application for oxidative stress marker of AKI.

Kasuno K, Shirakawa K, Yoshida H, Mori K, Kimura H, Takahashi N, Nobukawa Y, Shigemi K, Tanabe S, Yamada N, Koshiji T, Nogaki F, Kusano H, Ono T, Uno K, Nakamura H, Yodoi J, Muso E, Iwano M.

Am J Physiol Renal Physiol. 2014 Dec 15;307(12):F1342-51. doi: 10.1152/ajprenal.00381.2013. Epub 2014 Oct 1.

17.

Immediate therapeutic efficacy of low-density lipoprotein apheresis for drug-resistant nephrotic syndrome: evidence from the short-term results from the POLARIS Study.

Muso E, Mune M, Hirano T, Hattori M, Kimura K, Watanabe T, Yokoyama H, Sato H, Uchida S, Wada T, Shoji T, Yuzawa Y, Takemura T, Sugiyama S, Nishizawa Y, Ogahara S, Yorioka N, Sakai S, Ogura Y, Yukawa S, Iino Y, Imai E, Matsuo S, Saito T.

Clin Exp Nephrol. 2015 Jun;19(3):379-86. doi: 10.1007/s10157-014-0996-8. Epub 2014 Jun 17.

PMID:
24934117
18.

[Therapy and prognosis of medium and small vessel vasculitis].

Muso E.

Nihon Jinzo Gakkai Shi. 2014;56(2):105-16. Review. Japanese. No abstract available.

PMID:
24730348
19.

Twisted gastrulation, a BMP antagonist, exacerbates podocyte injury.

Yamada S, Nakamura J, Asada M, Takase M, Matsusaka T, Iguchi T, Yamada R, Tanaka M, Higashi AY, Okuda T, Asada N, Fukatsu A, Kawachi H, Graf D, Muso E, Kita T, Kimura T, Pastan I, Economides AN, Yanagita M.

PLoS One. 2014 Feb 25;9(2):e89135. doi: 10.1371/journal.pone.0089135. eCollection 2014.

20.

Beneficial effect of LDL-apheresis in refractory nephrotic syndrome.

Muso E.

Clin Exp Nephrol. 2014 Apr;18(2):286-90. doi: 10.1007/s10157-013-0930-5. Epub 2014 Feb 18. Review.

Supplemental Content

Loading ...
Support Center